Host Factor SAMHD1 Restricts DNA Viruses in Non-Dividing Myeloid Cells

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Hollenbaugh, Joseph A ^a,b   Gee, Peter ^c   Baker, Jonathon ^a   Daly, Michele B ^a,b   Amie, Sarah M ^a   Tate, Jessica ^a   Kasai, Natsumi ^c   Kanemura, Yuka ^c   Kim, Dong Hyun ^d   Ward, Brian M ^a   Koyanagi, Yoshio ^c   Kim, Baek ^a,b,d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; SAMHD1; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA VIRUS; FLUORESCENCE ACTIVATED CELL SORTING; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MACROPHAGE; REAL TIME POLYMERASE CHAIN REACTION; VACCINIA; VACCINIA VIRUS; VIRUS CULTURE; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MONOMERIC GTP-BINDING PROTEINS; MYELOID CELLS; VACCINIA VIRUS; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 1; VACCINIA VIRUS;

EID: 84879511277     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003481     Document Type: Article

References (66)

1. Craveiro M, Clerc I, Sitbon M, Taylor N, (2013) Metabolic pathways as regulators of HIV infection. Current Opinion in HIV and AIDS 8: 182-189.
2. Bugianesi E, Salamone F, Negro F, (2012) The interaction of metabolic factors with HCV infection: does it matter? Journal of hepatology 56 Suppl 1: S56-65.
3. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD, (2006) Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2: e132.
4. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, et al. (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26: 1179-1186.
5. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
6. Kim B, Nguyen LA, Daddacha W, Hollenbaugh JA, (2012) Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J Biol Chem 287: 21570-21574.
7. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
8. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, et al. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13: 223-228.
9. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480: 379-382.
10. Powell RD, Holland PJ, Hollis T, Perrino FW, (2011) The Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 286: 43596-43600.
11. Jamburuthugoda VK, Chugh P, Kim B, (2006) Modification of human immunodeficiency virus type 1 reverse transcriptase to target cells with elevated cellular dNTP concentrations. J Biol Chem 281: 13388-13395.
12. Traut TW, (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1-22.
13. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, et al. (2004) Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 279: 51545-51553.
14. Kennedy EM, Gavegnano C, Nguyen L, Slater R, Lucas A, et al. (2010) rNTPs as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages. J Biol Chem 285: 39380-39391.
15. Amie SM, Noble E, Kim B, (2013) Intracellular nucleotide levels and the control of retroviral infections. Virology 436: 247-254.
16. Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, et al. (2009) The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol 83: 4854-4860.
17. Goujon C, Arfi V, Pertel T, Luban J, Lienard J, et al. (2008) Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J Virol 82: 12335-12345.
18. St Gelais C, de Silva S, Amie SM, Coleman CM, Hoy H, et al. (2012) SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology 9: 105.
19. Bobadilla S, Sunseri N, Landau NR, (2012) Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther 20: 514-520.
20. Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, et al. (2012) SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 9: 87.
21. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, et al. (2012) SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Medicine 18: 1682-1689.
22. Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, et al. (2011) SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathogens 7: e1002425.
23. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, et al. (2009) Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41: 829-832.
24. White TE, Brandariz-Nunez A, Carlos Valle-Casuso J, Amie S, Nguyen L, et al. (2012) Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 436: 81-90.
25. Rubins KH, Hensley LE, Relman DA, Brown PO, (2011) Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One 6: e15615.
26. Eitz Ferrer P, Potthoff S, Kirschnek S, Gasteiger G, Kastenmuller W, et al. (2011) Induction of Noxa-mediated apoptosis by modified vaccinia virus Ankara depends on viral recognition by cytosolic helicases, leading to IRF-3/IFN-beta-dependent induction of pro-apoptotic Noxa. PLoS Pathogens 7: e1002083.
27. Stinski MF, Meier JL (2007) Immediate-early viral gene regulation and function. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge.
28. Bustos J, Gomez B, (1999) Characteristics of a macrophage culture persistently infected with herpes simplex virus type 1. Arch Med Res 30: 255-262.
29. Domke-Opitz I, Poberschin P, Mittnacht S, Kirchner H, (1987) Role of interferon in persistent infection of macrophages with herpes simplex virus. Virology 159: 306-311.
30. Lopez-Guerrero JA, Alonso MA, (1997) Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells. J Gen Virol 78 (Pt 8):: 1977-1980.
31. Rubenstein R, Price RW, (1983) Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: infection of the PC 12 cell. Arch Virology 78: 49-64.
32. Jacobson JG, Leib DA, Goldstein DJ, Bogard CL, Schaffer PA, et al. (1989) A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173: 276-283.
33. Ward BM, (2005) Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J Virol 79: 4755-4763.
34. Hofmann H, Logue EC, Bloch N, Daddacha W, Polsky SB, et al. (2012) The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol 86: 12552-12560.
35. Berger G, Durand S, Goujon C, Nguyen XN, Cordeil S, et al. (2011) A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Nat Protoc 6: 806-816.
36. Buller RM, Smith GL, Cremer K, Notkins AL, Moss B, (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317: 813-815.
37. Zeh HJ, Bartlett DL, (2002) Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers. Cancer Gene Therapy 9: 1001-1012.
38. Munch-Petersen B, (2010) Enzymatic regulation of cytosolic thymidine kinase 1 and mitochondrial thymidine kinase 2: a mini review. Nucleosides, Nucleotides & Nucleic Acids 29: 363-369.
39. Planelles V, (2011) Restricted access to myeloid cells explained. Viruses 3: 1624-1633.
40. St Gelais C, Wu L, (2011) SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 8: 55.
41. Hruby DE, Ball LA, (1981) Control of expression of the vaccinia virus thymidine kinase gene. J Virol 40: 456-464.
42. Gammon DB, Gowrishankar B, Duraffour S, Andrei G, Upton C, et al. (2010) Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathogens 6: e1000984.
43. Smee DF, Martin JC, Verheyden JP, Matthews TR, (1983) Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrobial Agents and Chemotherapy 23: 676-682.
44. Cotter CR, Kim WK, Nguyen ML, Yount JS, Lopez CB, et al. (2011) The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-kappaB in dendritic cells in the absence of type I interferon signaling. J Virol 85: 12662-12672.
45. Kummer M, Turza NM, Muhl-Zurbes P, Lechmann M, Boutell C, et al. (2007) Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J Virol 81: 6326-6338.
46. Post LE, Mackem S, Roizman B, (1981) Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell 24: 555-565.
47. Lousberg EL, Diener KR, Brown MP, Hayball JD, (2011) Innate immune recognition of poxviral vaccine vectors. Expert Rev Vaccines 10: 1435-1449.
48. Walsh SR, Dolin R, (2011) Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines 10: 1221-1240.
49. Satoh T, Arase H, (2008) HSV-1 infection through inhibitory receptor, PILRalpha. Uirusu 58: 27-36.
50. Bahar MW, Graham SC, Chen RA, Cooray S, Smith GL, et al. (2011) How vaccinia virus has evolved to subvert the host immune response. J Struct Biology 175: 127-134.
51. Laing KJ, Dong L, Sidney J, Sette A, Koelle DM, (2012) Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses. Clinical Exp Immuno 167: 47-58.
52. Puigdomenech I, Casartelli N, Porrot F, Schwartz O, (2012) SAMHD1 Restricts HIV-1 Cell-to-Cell Transmission And Limits Immune Detection In Monocyte-Derived Dendritic Cells. J Virol 87: 2846-2856.
53. Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B, (1993) Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195: 732-744.
54. Placek BJ, Berger SL, (2010) Chromatin dynamics during herpes simplex virus-1 lytic infection. Biochimica Biophysica Acta 1799: 223-227.
55. Liashkovich I, Hafezi W, Kuhn JM, Oberleithner H, Shahin V, (2011) Nuclear delivery mechanism of herpes simplex virus type 1 genome. J Mole Recognition: JMR 24: 414-421.
56. Yan J, Kaur S, Delucia M, Hao C, Mehrens J, et al. (2013) Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection. J Biol Chem 288: 10406-10417.
57. Yao Y, Li P, Singh P, Thiele AT, Wilkes DS, et al. (2007) Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell Immuno 246: 92-102.
58. Huemer HP, Geiger M, Posch W, Krumbock N, Fresser F, et al. (2013) Protein kinase C overexpression does not enhance immune-stimulatory surface markers of vaccinia-infected dendritic cells and DC cell lines. Immunol Investigations 42: 164-177.
59. Smith RF, Freyer MW, Lewis EA, (2007) Biophysical characterization of vaccinia virus thymidine kinase substrate utilization. J Virol Methods 142: 151-158.
60. Ke PY, Hu CM, Chang YC, Chang ZF, (2007) Hiding human thymidine kinase 1 from APC/C-mediated destruction by thymidine binding. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 21: 1276-1284.
61. Salguero I, Guarino E, Shepherd ME, Deegan TD, Havens CG, et al. (2012) Ribonucleotide reductase activity is coupled to DNA synthesis via proliferating cell nuclear antigen. Current Biol: CB 22: 720-726.
62. Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, et al. (1990) The complete DNA sequence of vaccinia virus. Virology 179: 247-263, 247-266, 517-263.
63. Brown JC, (2007) High G+C Content of Herpes Simplex Virus DNA: Proposed Role in Protection Against Retrotransposon Insertion. The open Biochemistry Journal 1: 33-42.
64. Mock DJ, Hollenbaugh JA, Daddacha W, Overstreet MG, Lazarski CA, et al. (2012) Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. PLoS Pathog 8: e1002635.
65. Husain M, Moss B, (2001) Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles. J Virol 75: 7528-7542.
66. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.